Global X Uranium ETF vs 22nd Century Group Inc — how do they compare? Global X Uranium ETF trades at $45.31, while 22nd Century Group Inc trades at $4.07 (market cap $1.49M). The key difference: Global X Uranium ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| URA | XXII | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Technology |
52-Week High | $61.81 | $720.00 |
52-Week Low | $36.45 | $3.72 |
Market Cap | — | $1.49M |
Enterprise Value | — | -$6.74M |
Signals from Pluang's Aura AI — not financial advice
URA trades at $45.2, up 0.07% on the day, with a bullish technical signal driven by moving averages despite overbought RSI readings. Recent news highlights nuclear energy momentum from AI power demand and policy support, including a $17.5 billion U.S. loan program and Saudi nuclear deals. The ETF's holdings, like Cameco, benefit from rising uranium contract prices, though financial ratios are undisclosed.
Outlook is positive due to structural demand for nuclear power, but risks include regulatory shifts and valuation concerns after an 18.9% correction. Investors gain diversified exposure to uranium miners and nuclear services, with Wall Street sentiment leaning bullish on long-term themes.
XXII trades at $4.31, down 2.05% today, with a neutral technical signal despite bearish moving averages. The company shows severe financial distress with negative gross profit margin of -52.19% and net income margin of -65.76%, though revenue reached $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, while the company continues VLN® brand expansion in major markets.
The investment case hinges on successful commercialization of reduced-nicotine products, but persistent losses and high cash burn create substantial risk. Analyst consensus remains bullish with 75% buy ratings, suggesting optimism about turnaround potential despite fundamental weaknesses.
Trailing returns across standard periods
Latest headlines on both assets
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →